World's Best Scientists 2026 revealed!
Award Badge
Best Female Scientists
2025

D-Index & Metrics

Best Female Scientists

D-Index
140
Citations
70883
World Ranking
239
National Ranking
151

Medicine

D-Index
140
Citations
73840
World Ranking
1693
National Ranking
978

Research.com Recognitions

  • 2025 - Research.com Best Female Scientists Award

Overview

Ritsuko Komaki is affiliated with The University of Texas MD Anderson Cancer Center in the United States and has contributed extensively to research in the field of Medicine, specifically focusing on pulmonary and respiratory medicine, oncology, epidemiology, surgery, and radiology including nuclear medicine and imaging.

Their research output includes a variety of studies on lung cancer, neuroendocrine tumors, esophageal cancer, and advanced radiotherapy techniques. Main topics covered in their work include:

  • Lung Cancer Research Studies
  • Lung Cancer Treatments and Mutations
  • Lung Cancer Diagnosis and Treatment
  • Neuroendocrine Tumor Research Advances
  • Advanced Radiotherapy Techniques
  • Esophageal Cancer Research and Treatment
  • Radiomics and Machine Learning in Medical Imaging

Frequent publication venues for Komaki's research include:

  • Journal of Thoracic Oncology
  • Journal of Clinical Oncology
  • JAMA Network Open
  • International Journal of Radiation Oncology*Biology*Physics
  • JAMA Oncology

Komaki has collaborated with multiple researchers throughout their career. Frequent coauthors include:

  • Stephen G. Chun
  • Thomas E. Stinchcombe
  • J.A. Bogart
  • Steven H. Lin
  • Zhongxing Liao

Notable recent papers authored or coauthored by Komaki are:

  • Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for Locally Advanced Esophageal Cancer, 2020, Journal of Clinical Oncology
  • Phase 3 comparison of high-dose once-daily (QD) thoracic radiotherapy (TRT) with standard twice-daily (BID) TRT in limited stage small cell lung cancer (LSCLC): CALGB 30610 (Alliance)/RTOG 0538, 2021, Journal of Clinical Oncology
  • Long-Term Prospective Outcomes of Intensity Modulated Radiotherapy for Locally Advanced Lung Cancer, 2024, JAMA Oncology
  • Metabolic Responses to Metformin in Inoperable Early-stage Non-Small Cell Lung Cancer Treated With Stereotactic Radiotherapy, 2020, American Journal of Clinical Oncology
  • Association of Radiotherapy Duration With Clinical Outcomes in Patients With Esophageal Cancer Treated in NRG Oncology Trials, 2023, JAMA Network Open

Best Publications

  • Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study

    Jeffrey D. Bradley;Rebecca Paulus;Ritsuko Komaki;Gregory Masters

  • Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide

    Andrew T. Turrisi;Kyungmann Kim;Ronald Blum;William T. Sause

  • INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy.

    Bruce D. Minsky;Thomas F. Pajak;Robert J. Ginsberg;Thomas M. Pisansky

  • Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials

    Joe Y Chang;Suresh Senan;Marinus A. Paul;Reza John Mehran

  • Sequential vs Concurrent Chemoradiation for Stage III Non–Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410

    Walter J. Curran;Rebecca Paulus;Corey J. Langer;Ritsuko Komaki

  • A Randomized Trial Comparing Perioperative Chemotherapy and Surgery With Surgery Alone in Resectable Stage IIIA Non-Small-Cell Lung Cancer

    Jack A Roth;Frank V Fossella;Ritsuko Komaki;M. Bernadette Ryan

  • Non–Small Cell Lung Cancer

    David S. Ettinger;Wallace Akerley;Gerold Bepler;Andrew Chang

  • Non-small cell lung cancer, version 5.2017: Clinical practice guidelines in oncology

    David S. Ettinger;Douglas E. Wood;Dara L. Aisner;Wallace Akerley

  • Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study

    Daniel R Gomez;George R Blumenschein;J Jack Lee;Mike Hernandez

  • Radiation Therapy Oncology Group (RTOG) 88–08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary Results of a Phase III Trial in Regionally Advanced, Unresectable Non-Small-Cell Lung Cancer

    William T. Sause;Charles Scott;Samuel Taylor;David H Johnson

  • Final Results of Phase III Trial in Regionally Advanced Unresectable Non-Small Cell Lung Cancer : Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group

    William Sause;Patricia Kolesar;Samuel Taylor;David H Johnson

  • Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non–Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial

    Stephen G. Chun;Chen Hu;Hak Choy;Ritsuko U. Komaki

  • Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer

    Jack A Roth;E.Neely Atkinson;Frank Fossella;Ritsuko Komaki

  • PDL1 Regulation by p53 via miR-34

    Maria Angelica Abdalla Cortez;Cristina Ivan;David Valdecanas;Xiaohong Wang

  • A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer

    Steven M. Keller;Sudeshna Adak;Henry Wagner;Arnold Herskovic

  • Toxicity and outcome results of RTOG 9311: A phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma

    Jeffrey Bradley;Mary V. Graham;Kathryn Winter;James A. Purdy

  • Non-small cell lung cancer: Clinical practice guidelines in oncology

    David S. Ettinger;Wallace Akerley;Gerold Bepler;Matthew G. Blum

  • Survival and Neurologic Outcomes in a Randomized Trial of Motexafin Gadolinium and Whole-Brain Radiation Therapy in Brain Metastases

    Minesh P. Mehta;Patrick Rodrigus;C. H J Terhaard;Aroor Rao

  • Non-small cell lung cancer, version 2.2013: Featured updates to the NCCN guidelines

    David S. Ettinger;Wallace Akerley;Hossein Borghaei;Andrew C. Chang

  • Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation

    Lucian R. Chirieac;Stephen G. Swisher;Jaffer A. Ajani;Ritsuko R. Komaki

Frequent Co-Authors

Zhongxing Liao
Zhongxing Liao The University of Texas MD Anderson Cancer Center
James D. Cox
James D. Cox The University of Texas MD Anderson Cancer Center
Joe Y. Chang
Joe Y. Chang The University of Texas MD Anderson Cancer Center
Jaffer A. Ajani
Jaffer A. Ajani The University of Texas MD Anderson Cancer Center
Pamela K. Allen
Pamela K. Allen The University of Texas MD Anderson Cancer Center
Wayne L. Hofstetter
Wayne L. Hofstetter The University of Texas MD Anderson Cancer Center
Stephen G. Swisher
Stephen G. Swisher The University of Texas MD Anderson Cancer Center
Radhe Mohan
Radhe Mohan The University of Texas MD Anderson Cancer Center
Jack A. Roth
Jack A. Roth The University of Texas MD Anderson Cancer Center
David C. Rice
David C. Rice The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're interested in studying Medicine in the USA, there are several flexible online degree options and career pathways that can complement or serve as alternatives to a traditional medical degree. These programs are especially helpful for those seeking to advance their education or shift into specialized healthcare roles with greater flexibility.

For students passionate about the link between diet and health, explore the best online nutrition programs. These can open doors to careers in nutritional counseling, public health, and wellness education.

Aspiring healthcare administrators should consider the top online mha programs that are cahme accredited, designed to prepare you for leadership positions in hospitals and health systems.

For practicing registered nurses, online rn to bsn programs without clinicals offer a way to earn your bachelor’s degree with a schedule suited to working professionals, often without additional clinical requirements.

If you are aiming for the highest level in clinical practice, look into accelerated msn to dnp programs which allow qualified nurses to quickly achieve a Doctor of Nursing Practice degree.

Best Scientists Citing Ritsuko Komaki

Trending Scientists

Recently Published Articles